| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/12/2006 | EP1643996A1 Combination of src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases |
| 04/12/2006 | EP1643995A1 Treatment of migraine accompanied by nausea |
| 04/12/2006 | EP1643978A1 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 04/12/2006 | EP1643865A1 Nutritional compositions and use thereof |
| 04/12/2006 | EP1643862A1 Infant formula |
| 04/12/2006 | EP1441689B1 Solid oral compositions |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1395133B1 Polymer controlled induced viscosity fiber system and uses thereof |
| 04/12/2006 | EP1395132B1 Dual viscosity fibre system and uses thereof |
| 04/12/2006 | EP1355639B1 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1294394B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP1200040B1 Two-component composition for cosmetic or pharmaceutical use |
| 04/12/2006 | EP1194156B1 Dietary supplement for treating malignancies and viral infections and improving immune function |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1146851B1 Galenic formulation containing biotin |
| 04/12/2006 | EP1071956B1 Assays for autoantibodies |
| 04/12/2006 | EP0942739B1 Biomaterial derived from vertebrate liver tissue |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1758916A Method of treating and preventing hyperparathyroidism with vitamin D2 or D4 compounds |
| 04/12/2006 | CN1758905A Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/12/2006 | CN1757415A Supersensitivity-prevention type lubricant used for cervix forceps vaginoscope catheler and colpectasia dilator |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250711C Purging of cells using viruses |
| 04/12/2006 | CN1250559C Process for preparing amine platinum complexes |
| 04/12/2006 | CN1250545C Quinuclidine derivatives and medicine composition containing the derivatives |
| 04/12/2006 | CN1250290C Novel medicament compositions, based on anticholinergic effective compounds and beta-mimetiques |
| 04/12/2006 | CN1250289C Drugs, drinks or foods |
| 04/12/2006 | CN1250286C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/12/2006 | CN1250281C Method for treating endothelium wound |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250229C Transdermic administrated external-use medicine composition |
| 04/12/2006 | CN1250220C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 04/12/2006 | CN1250219C Pharmaceutical composition |
| 04/12/2006 | CN1250202C Foaming cosmetic paste |
| 04/11/2006 | US7026505 Method of treating tinnitus |
| 04/11/2006 | US7026337 Gel formulations of hydroxypyridone derivatives, which contain solvents and hydrophilic gel-forming agents make possible a high release of the active compound |
| 04/11/2006 | US7026332 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder, specific social phobia, premenstrual dysphoric disorder, and other psychological disorders |
| 04/11/2006 | US7026330 Administering mixtures of rapamycin and/or derivatives and interleukin antagonists, for prophylaxis of blood disorders; anticarcinogenic agents |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026304 especially for blocking rocuronium, vecuronium, pancuronium and rapacuronium salts; kits. |
| 04/11/2006 | US7026302 Compositions and methods for treating mammals with modified alginates and modified pectins |
| 04/11/2006 | US7026298 Diarrhea therapy; gel mouth rehydration solution |
| 04/11/2006 | US7026295 Administering a lactoferrin formulation to provide therapy for cardiovascular disease |
| 04/11/2006 | US7026293 Comprising active ingredient such as atrial natriuretic peptide which can increase cGMP production by acting on natriuretic peptide receptor, and which reduces an infarct region |
| 04/11/2006 | US7026285 Immunomodulating polymers |
| 04/11/2006 | US7026280 Polypeptides; nervous system, brain disorders |
| 04/11/2006 | US7026161 Lactobacillus sp. strain and use thereof |
| 04/11/2006 | US7026160 Oral bacteriotherapy compositions and methods |
| 04/11/2006 | US7026136 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025991 Nanoparticle drug delivery |
| 04/11/2006 | US7025990 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/11/2006 | US7025989 At least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | US7025978 Use of polysiloxanes containing quarternary amino groups as formulation auxiliary agents, and agents containing the same |
| 04/11/2006 | US7025977 Mixture of hydroquinone and ascorbic compound |
| 04/11/2006 | US7025719 Metallic cardiac support device |
| 04/11/2006 | CA2204375C Methods for the diagnosis of glaucoma |
| 04/11/2006 | CA2178632C Pharmaceutical compositions containing hiv protease inhibitors |
| 04/07/2006 | CA2522152A1 Transdermal and transmucosal preparations |
| 04/06/2006 | WO2006037029A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 04/06/2006 | WO2006036484A2 Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
| 04/06/2006 | WO2006035796A1 1-(β-D-GLYCOPYRANOSYL)-3-SUBSTITUTED NITROGENOUS HETEROCYCLIC COMPOUND, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF |
| 04/06/2006 | WO2006035702A1 C-peptide specific binding molecule and use thereof |
| 04/06/2006 | WO2006035673A1 Novel method of protecting ischemic cardiopathy |
| 04/06/2006 | WO2006034873A1 METHODS FOR THE GENERATION OF HEPATOCYTE-LIKE CELLS FROM HUMAN BLASTOCYST-DERIVED STEM (hBs) |
| 04/06/2006 | WO2005110375A8 Nutritional supplement for treatment of ocular diseases |
| 04/06/2006 | WO2005110022A3 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 04/06/2006 | WO2005082386A3 Manganese and iron based compounds for elastogenesis and connective tissue treatment |
| 04/06/2006 | WO2005074982A3 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 04/06/2006 | WO2005074900A3 NOVEL COMBINATION OF ANTICHOLINERGIC AND β MIMETICS FOR THE TREATMENT OF RESPIRATORY DISEASES |
| 04/06/2006 | WO2005053795A3 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
| 04/06/2006 | WO2005049065A3 Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections |
| 04/06/2006 | WO2005026783A3 Method for configuring air-core photonic-bandgap fibers free of surface modes |
| 04/06/2006 | WO2005017127A3 Rna interference compositions and methods |
| 04/06/2006 | WO2004105768A8 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 04/06/2006 | US20060074377 Microprojection array immunization patch and method |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074107 Pharmaceutically active piperidine derivatives |
| 04/06/2006 | US20060074104 Use of clioquinol for the therapy of alzheimer's disease |
| 04/06/2006 | US20060074094 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 04/06/2006 | US20060074090 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety |
| 04/06/2006 | US20060074080 Combination product comprising melagatran and an anti-arrhythmic oxabispidenes |
| 04/06/2006 | US20060074078 Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer |
| 04/06/2006 | US20060074070 1-Methyl, 2-((2-(2-(guanidinoethyl(dimethylammonium)ethyl-)(naphthyl-1,5-ylene)oxymethyl-),6-(1-hydroxyethyl-)carbapen-2-em-3-carboxylate; 1-methylcarbapenems as bactericides; drug resistance; multidrug resistance; methicillin-resistant Staphylococcus aureus (MRSA) and S. epidermidis(MRSE) |
| 04/06/2006 | US20060074063 Pharmacological agent and method of treatment |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060074052 Compositions and methods for treating mammals with modified alginates and modified pectins |
| 04/06/2006 | US20060074051 comprising a stem cell and a plurality of amino acids having an alpha carbon, the amino acids being present at a molar ratio which is characteristic of human breast milk protein, and wherein no more than 10% of the amino acids are in D-form |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074039 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 04/06/2006 | US20060074038 Her-2 neu dna vaccine having anti-cancer activity |
| 04/06/2006 | US20060074027 Microcapsules of luteinizing hormone releasing hormone agonists; glycolic acid-lactic acid copolymers; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, precocious puberty, dymenorrhea or breast cancer, or inhibiting conception |
| 04/06/2006 | US20060074013 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 04/06/2006 | US20060074012 Treatment of gestational diabetes |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |